Furosemide 100 mg added to 0 — Class I drug recall D-1189-2018
Terminated recall by SCA Pharmaceuticals, Inc., reported 2018-09-19, distributed in CT, DC, VA. Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingre
| Recall number | D-1189-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SCA Pharmaceuticals, Inc., Little Rock, AR, United States |
| Recall initiated | 2018-08-27 |
| Classified | 2018-09-12 |
| Reported by FDA | 2018-09-19 |
| Terminated | 2020-06-02 |
| Distributed | CT, DC, VA |
| Quantity | 1,384 bags |
| Expiration dates | 2018-10-03, 2018-10-04, 2018-10-05, 2018-10-19, 2018-10-26 |
Product
Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205, 877.550.5059, barcode 70004063032.
Reason for recall
Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1189-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.